Adalimumab for the treatment of refractory acne conglobata

Freja Lærke Sand; Simon Francis Thomsen

doi:10.1001/jamadermatol.2013.6678

Adalimumab for the treatment of refractory acne conglobata

Dermato- & Venerologisk Afd.

23 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	JAMA dermatology (Chicago, Ill.)
Vol/bind	149
Udgave nummer	11
Sider (fra-til)	1306-7
Antal sider	2
DOI	https://doi.org/10.1001/jamadermatol.2013.6678
Status	Udgivet - nov. 2013

Adgang til dokumentet

10.1001/jamadermatol.2013.6678

Citationsformater

@article{cd6ec2928a3442838e9d65c07cd3a34c,

title = "Adalimumab for the treatment of refractory acne conglobata",

keywords = "Acne Vulgaris, Adolescent, Anti-Inflammatory Agents, Antibodies, Monoclonal, Humanized, Face, Humans, Male, Treatment Outcome, Tumor Necrosis Factor-alpha",

author = "Sand, {Freja L{\ae}rke} and Thomsen, {Simon Francis}",

year = "2013",

month = nov,

doi = "10.1001/jamadermatol.2013.6678",

language = "English",

volume = "149",

pages = "1306--7",

journal = "JAMA dermatology (Chicago, Ill.)",

issn = "2168-6084",

publisher = "American Medical Association",

number = "11",

}

TY - JOUR

T1 - Adalimumab for the treatment of refractory acne conglobata

AU - Sand, Freja Lærke

AU - Thomsen, Simon Francis

PY - 2013/11

Y1 - 2013/11

KW - Acne Vulgaris

KW - Adolescent

KW - Anti-Inflammatory Agents

KW - Antibodies, Monoclonal, Humanized

KW - Face

KW - Humans

KW - Male

KW - Treatment Outcome

KW - Tumor Necrosis Factor-alpha

U2 - 10.1001/jamadermatol.2013.6678

DO - 10.1001/jamadermatol.2013.6678

M3 - Journal article

C2 - 24048280

SN - 2168-6084

VL - 149

SP - 1306

EP - 1307

JO - JAMA dermatology (Chicago, Ill.)

JF - JAMA dermatology (Chicago, Ill.)

IS - 11

ER -